COSCIENS Biopharma Inc banner

COSCIENS Biopharma Inc
OTC:CSCIF

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
OTC:CSCIF
Watchlist
Price: 2.05 USD 0.49% Market Closed
Market Cap: $6.5m

Wall St Price Targets

CSCIF Price Targets Summary
COSCIENS Biopharma Inc

There are no price targets for CSCIF.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
COSCIENS Biopharma Inc Competitors:
Price Targets

Revenue
Forecast

3% / Year
Past Growth
-42% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
3% / Year
Past Growth
-42% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 1 year is -42%.

Gross Profit
Forecast

-4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for COSCIENS Biopharma Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for COSCIENS Biopharma Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-97%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-97%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CSCIF's stock price target?
Not Available

CSCIF does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for COSCIENS Biopharma Inc?
Projected CAGR
-42%

Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 1 year is -42%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett